glp 1 and anesthesia risk GLP-1 RA guidance roundup 📌 Anesthetic risks associated with

I wont get it perfect every day, but I want to continue to make good choices as much as I can

Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults For the first time, a GLP-1 therapy has been cleared to treat metabolic dysfunction-associated steatohepatitis (MASH), after the US Food and Drug Administration (FDA) granted accelerated approval to Novo Nordisks weight-loss drug Wegovy

The regulator said it is actively monitoring the marketplace

That said, individual response varies and the medication that suits you best depends on your health history and how you titrate your dose

Around the globe, increasing collaborations between pharmaceutical companies and hospitals are escalating patient treatment rates

Curr Pharm Des (2003) 9:137382